清水源(300437) - 2022 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2022 reached ¥431,547,506.16, representing a 37.49% increase compared to the same period last year[5] - Year-to-date revenue as of Q3 2022 was ¥1,451,476,378.54, showing a 35.28% increase from the previous year[5] - Total operating revenue for the period reached ¥1,451,476,378.54, a 35.2% increase from ¥1,072,905,470.18 in the previous period[18] - Total operating costs amounted to ¥1,296,122,721.89, up 23.2% from ¥1,051,892,173.61 year-on-year[18] - Net profit for the period was ¥111,860,086.71, compared to ¥12,080,921.46 in the same period last year, representing a significant increase[19] - The net profit attributable to shareholders decreased by 88.87% to ¥5,491,608.43, while the net profit after deducting non-recurring gains and losses fell by 60.98% to ¥7,466,788.41[5] - The company reported a significant increase in net profit attributable to shareholders for the first nine months of 2022, up 458.25% to ¥112,326,159.46[9] Assets and Liabilities - The company's total assets decreased by 7.09% to ¥3,330,390,462.21 compared to the end of the previous year[5] - As of September 30, 2022, the total assets of Henan Qingshuiyuan Technology Co., Ltd. amounted to CNY 3,330,390,462.21, a decrease from CNY 3,584,419,971.31 at the beginning of the year[15] - The total current liabilities decreased from CNY 1,782,855,116.52 to CNY 1,334,788,859.75, indicating a reduction of approximately 25.0%[16] - Total liabilities decreased to ¥1,578,649,008.01 from ¥1,941,725,959.06, indicating improved financial stability[19] - Long-term borrowings increased by 65.41% to ¥219,662,932.47, primarily due to new loans for PPP projects[9] - Long-term borrowings increased to CNY 219,662,932.47 from CNY 132,800,000.00, reflecting a rise of about 65.3%[16] Cash Flow - Cash flow from operating activities showed a drastic decline of 93.44%, totaling ¥9,711,094.43 year-to-date[5] - Cash flow from operating activities generated a net amount of ¥9,711,094.43, a decrease from ¥148,107,749.51 in the previous period[21] - The net cash flow from investment activities was -43,453,235.45 CNY, a decrease compared to -76,178,745.37 CNY in the previous period[22] - The total cash inflow from financing activities was 1,227,157,751.88 CNY, up from 1,017,085,922.96 CNY year-over-year[22] - The net cash flow from financing activities was 49,930,589.61 CNY, a significant improvement from -214,653,869.16 CNY in the previous period[22] - The cash and cash equivalents at the end of the period amounted to 281,407,723.29 CNY, compared to 178,996,265.17 CNY at the end of the previous period[22] - The company received cash from borrowings totaling 672,063,132.45 CNY, compared to 656,929,900.00 CNY in the previous period[22] - The cash outflow for repaying debts was 635,856,640.86 CNY, an increase from 525,543,786.56 CNY year-over-year[22] - The cash inflow from other financing activities was 555,094,619.43 CNY, compared to 360,156,022.96 CNY in the previous period[22] - The net increase in cash and cash equivalents was 18,696,247.84 CNY, contrasting with a decrease of -142,473,103.22 CNY in the previous period[22] Shareholder Value - The basic earnings per share for Q3 2022 was ¥0.0212, down 90.49% year-on-year[5] - Basic earnings per share increased to ¥0.4336 from ¥0.0909, reflecting improved profitability[20] - Total equity attributable to shareholders increased to ¥1,734,665,926.43 from ¥1,625,282,086.74, showing growth in shareholder value[19] Legal Matters - The company has received a final judgment in a lawsuit against Li Wanshuang, requiring payment of CNY 70 million plus interest, with CNY 8,949,944.16 already collected[12] - The second phase of the equity repurchase lawsuit against Li Wanshuang has a judgment requiring payment of CNY 90 million plus interest, which is currently in the enforcement stage[13] - The company plans to closely monitor the progress of ongoing litigation and take necessary measures to protect the interests of the company and its shareholders[13] Other Financial Metrics - Research and development expenses were ¥16,616,216.72, down from ¥22,767,214.04, indicating a potential shift in investment strategy[18] - Other comprehensive income after tax was ¥224,684.32, compared to a loss of ¥11,813.15 in the previous period, reflecting improved financial performance[20] - The company reported a credit impairment loss of ¥4,334,542.42, a significant reduction from ¥45,849,008.66 in the previous period, indicating better asset quality[19] - The company received government subsidies amounting to ¥1,428,905.04 during the reporting period, contributing to its financial performance[6] Inventory and Receivables - Accounts receivable increased to CNY 390,605,037.32 from CNY 338,273,140.22, representing a growth of about 15.5%[15] - The inventory decreased significantly from CNY 206,760,460.09 to CNY 155,954,361.98, a reduction of approximately 24.6%[15] Project Development - The company is actively progressing on the phosphorus pentachloride project, which aims for an annual production capacity of 100,000 tons[13] Audit Status - The company did not conduct an audit for the third quarter report[23]